To better compare CSF NfL species in Alzheimer’s disease, non-Alzheimer’s disease dementia and healthy controls, we developed a quantitative NfL assay to reliably measure select regions across multiple NfL species. The gene discussed is NEFL; the disease is early-onset autosomal dominant Alzheimer disease.